Skip to content

Efficacy and cost-effectiveness analysis of oral diclofenac sodium 3 days, 7 days for conventional radiofrequency denervation in the treatment of chronic facet joint pain: double-blinded randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN68542008
Enrollment
66
Registered
2008-09-12
Start date
2008-09-03
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back facet joints pain Signs and Symptoms Other joint disorders, not elsewhere classified

Interventions

Arm 1: Placebo 3 times daily (tid) for 7 days Arm 2: Diclofenac sodium 25 mg tid for 3 days and placebo tid for following 4 days Arm 3: Diclofenac sodium 25 mg tid for 7 days Total duration of treatm

Sponsors

Shanghai Sixth People's Hospital (China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, age greater than 18 years 2. Duration of facet joints pain more than 6 months 3. Oswestry disability index 20%+ 4. Unresponsiveness to traditional conservative treatments such as bed rest, medication, physical therapy, trigger point injection and epidural block

Exclusion criteria

Exclusion criteria: 1. Prior radiofrequency treatment 2. Coagulation disturbances 3. Allergies to local anaesthetic 4. Malignancy 5. Mental handicap or psychiatric condition precluding adequate communication, language problems 7. Unstable medical or psychiatric condition 8. Pregnancy 9. No effect of diagnostic blockades (one or two) 10. Gastrointestinal tract ulcer 11. Radicular syndrome 12. Indication for low back surgery

Design outcomes

Primary

MeasureTime frame
1. Pain, measured by a visual analogue scale (VAS) at baseline, Day 7, 14, 30, 60 2. Oswestry Disability Index (ODI) at baseline, Day 30 and 60 3. Cost-effectiveness analysis at 60 days

Secondary

MeasureTime frame
1. Overall patients' satisfaction, measured by Patients' Satisfaction Score (3: excellent; 2: good; 1: moderate; 0: bad) at Day 60 2. Number needed to treat (NNT) to obtain one patient with good or complete pain relief at Day 60 3. Dosage of rescue drug. Duration of follow-up: 60 days after radiofrequency denervation. 4. Presence, frequency and duration of adverse effects at Day 7, 14, 30, 60

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026